ADIPOQ and metabolic dysfunction-associated steatohepatitis: Adiponectin is an adipose-secreted cytokine that correlates negatively with insulin resistance, plasma triglycerides and low-density lipoprotein (LDL) – cholesterol, hepatic fat content and progression to NASH in NAFLD patients [22], [23].